Adding to the catalogue of indications that demonstrates the potential of NNZ 2591 is vitally important in building value around the molecule. I'm OK if they don't progress to trials like the first three have, but you've got a CSO like Larry Glass, best use him and his team to see what other opportunities attach here. Pleased to hear Jon say that that ongoing investigation of 2591 continues.
Ann: Notification of investor briefing webinar, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.04 |
Change
0.185(1.44%) |
Mkt cap ! $1.628B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $5.423M | 413.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 57 | $13.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.04 | 725 | 10 |
View Market Depth
| Last trade - 14.22pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |